Cargando…
Growth of cultured human glioma tumour cells can be regulated with histamine and histamine antagonists.
The 50% survival time for low grade astrocytomas is 50 months and for high grade astrocytomas it is 13 months, underlining the need for new therapies. Several reports show that in vivo histamine antagonists cause retardation of tumour growth in some animal models and prolonged survival in cancer pat...
Autores principales: | Van der Ven, L. T., Prinsen, I. M., Jansen, G. H., Roholl, P. J., Defferrari, R., Slater, R., Den Otter, W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968386/ https://www.ncbi.nlm.nih.gov/pubmed/8353038 |
Ejemplares similares
-
Histamine-stimulated expression of insulin-like growth factors in human glioma cells.
por: Van der Ven, L. T., et al.
Publicado: (1997) -
Histamine Formation and Tumour Growth
por: Buttle, G. A. H., et al.
Publicado: (1962) -
Interleukin-2 and histamine in combination inhibit tumour growth and angiogenesis in malignant glioma
por: Johansson, M, et al.
Publicado: (2000) -
Histamine and Skin Barrier: Are Histamine Antagonists Useful for the Prevention or Treatment of Atopic Dermatitis?
por: De Benedetto, Anna, et al.
Publicado: (2015) -
Histamine antagonists promote cancer immunosurveillance
por: Liu, Peng, et al.
Publicado: (2023)